Quick Answer
Akso Health Group reported Stockholders Equity of $199.12 million for fiscal year 2025.
Akso Health Group Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $199.12M | +43.9% |
| 2024 | $138.37M | +1485.8% |
| 2023 | $8.73M | -29.0% |
| 2022 | $12.28M | -28.9% |
| 2021 | $17.27M | +0.0% |
| 2021 | $17.27M | -64.1% |
| 2020 | $48.10M | -62.0% |
| 2019 | $126.50M | -9.7% |
| 2018 | $140.04M | +495.8% |
| 2017 | $23.50M | +67.7% |
| 2016 | $14.01M | +317.7% |
| 2015 | $3.35M | — |
- Akso Health Group showed an increase of +43.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, Akso Health Group’s stockholders equity has grown by 5835.7% (from $3.35 million to $199.12 million).
- The most recent figure is from Akso Health Group’s fiscal year 2025 report (Form 20-F), filed with the SEC on August 14, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: